A-S Medication Solutions Announces Strategic Transition

LIBERTYVILLE, Ill., July 01, 2024 (GLOBE NEWSWIRE) -- A-S Medication Solutions (ASM) today announced a strategic transition of its relationship with Triple Aim Consulting, LLC (“TAC”).

For a number of years, ASM has had a consulting agreement with TAC for TAC to assist ASM in managing client accounts. That consulting agreement ended on June 28, 2024.

“ASM is committed to increasing access to medications all across the United States,” said ASM CEO Matt Hoff.  “We are proud of our tireless dedication to serving patients in all 50 states.”

Matt Hoff 
Chief Executive Officer 
(678) 488-7524 

https://www.a-smeds.com/testimonials

You May Also Be Interested In

• TAIONE Open Source Foundation and Embedded LLM Collaborate to Build Taiwan's vLLM Ecosystem
• Global Power Solutions signs non-binding LOI with SolarZone Energy for potential deployment of modular power systems
• Niu Technologies Announces Unaudited Second Quarter 2026 Financial Results